Anti-C5orf60 monoclonal antibody

Pre-made anti-C5orf60 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to C5orf60/C5orf60 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-IP2863-Ab-1/ GM-Tg-hg-IP2863-Ab-2Anti-Human C5orf60 monoclonal antibodyHuman
GM-Tg-rg-IP2863-Ab-1/ GM-Tg-rg-IP2863-Ab-2Anti-Rat C5orf60 monoclonal antibodyRat
GM-Tg-mg-IP2863-Ab-1/ GM-Tg-mg-IP2863-Ab-2Anti-Mouse C5orf60 monoclonal antibodyMouse
GM-Tg-cynog-IP2863-Ab-1/ GM-Tg-cynog-IP2863-Ab-2Anti-Cynomolgus/ Rhesus macaque C5orf60 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-IP2863-Ab-1/ GM-Tg-felg-IP2863-Ab-2Anti-Feline C5orf60 monoclonal antibodyFeline
GM-Tg-cang-IP2863-Ab-1/ GM-Tg-cang-IP2863-Ab-2Anti-Canine C5orf60 monoclonal antibodyCanine
GM-Tg-bovg-IP2863-Ab-1/ GM-Tg-bovg-IP2863-Ab-2Anti-Bovine C5orf60 monoclonal antibodyBovine
GM-Tg-equg-IP2863-Ab-1/ GM-Tg-equg-IP2863-Ab-2Anti-Equine C5orf60 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-IP2863-Ab-1/ GM-Tg-hg-IP2863-Ab-2; GM-Tg-rg-IP2863-Ab-1/ GM-Tg-rg-IP2863-Ab-2;
GM-Tg-mg-IP2863-Ab-1/ GM-Tg-mg-IP2863-Ab-2; GM-Tg-cynog-IP2863-Ab-1/ GM-Tg-cynog-IP2863-Ab-2;
GM-Tg-felg-IP2863-Ab-1/ GM-Tg-felg-IP2863-Ab-2; GM-Tg-cang-IP2863-Ab-1/ GM-Tg-cang-IP2863-Ab-2;
GM-Tg-bovg-IP2863-Ab-1/ GM-Tg-bovg-IP2863-Ab-2; GM-Tg-equg-IP2863-Ab-1/ GM-Tg-equg-IP2863-Ab-2
Products NameAnti-C5orf60 monoclonal antibody
Formatmab
Target NameC5orf60
Protein Sub-locationIntrocelluar Protein
Category of antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-C5orf60 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-IP2863-Ag-1Recombinant multi-species CE060/ C5orf60 protein


    Target information

    Target IDGM-IP2863
    Target NameC5orf60
    Gene ID285679
    Gene Symbol and SynonymsC5orf60
    Uniprot AccessionA6NFR6
    Uniprot Entry NameCE060_HUMAN
    Protein Sub-locationIntrocelluar Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000204661
    Target ClassificationN/A

    The target: C5orf60, gene name: C5orf60, also named as . Note: This locus is considered non-coding by other groups due to a lack of experimental support for the protein, but NCBI annotates the protein because it meets minimal RefSeq quality criteria for representation. The coding status remains uncertain. [09 Mar 2015].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.